News
02-11-2014, 11:11 PM
A new study led by University of Kentucky Markey Cancer Center researcher Peter Zhou shows that targeting Twist, a nuclear protein that is an accelerant of the epithelial-mesenchymal transition (EMT) program in human cells, may provide an effective approach for treating triple-negative breast cancer.
More... (http://www.news-medical.net/news/20140212/EMT-program-in-human-cells-may-provide-an-effective-approach-for-treating-triple-negative-breast-cancer.aspx)
More... (http://www.news-medical.net/news/20140212/EMT-program-in-human-cells-may-provide-an-effective-approach-for-treating-triple-negative-breast-cancer.aspx)